New Your Times - Health - F.D.A. Approves New H.I.V.-Prevention Drug, but Not for Everyone

By APOORVA MANDAVILLI
NYT Health
Citing a lack of evidence, the agency will require Gilead to conduct additional trials in individuals ‘who have receptive vaginal sex.’
Published date: October 4, 2019 at 03:00AM